US2015118178A1PendingUtilityA1
Conjugates comprising an n-oxime bond and associated methods
Est. expiryJun 24, 2030(~3.9 yrs left)· nominal 20-yr term from priority
A61K 39/0008A61K 2039/627A61K 39/385C07B 43/00A61K 47/549A61K 2039/6093A61K 47/61A61K 31/436A61K 47/6933A61K 47/48176A61K 47/4823A61K 47/48092A61K 47/6937A61K 47/593A61K 47/6939
66
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Conjugates comprising a N-oxime bond are disclosed. In one embodiment, a suitable conjugate is represented by the following Formula (I): wherein R′ is derived from a compound comprising at least one reactive amide group, R″ is derived from a compound comprising at least one reactive aminooxy group, and X is H, C n H (n+2) or other atoms. Additional methods are also provided.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A composition comprising a conjugate represented by the following Formula (I):
wherein R′ is derived from a first compound comprising at least one reactive amide group, R″ is derived from a second compound comprising at least one reactive aminooxy group, wherein the second compound is selected from the group consisting of a polymer, a polysaccharide, a saccharide, a nucleic acid and a small molecule, and X is H, C n H (n+2) .
2 . The composition of claim 1 further comprising at least one additional N-oxime bond so as to form a crosslinked composition.
3 . The composition of claim 1 wherein the first compound is selected from the group consisting of a polymer, a protein, a peptide, a polysaccharide, a saccharide, a nucleic acid and a small molecule.
4 . The composition of claim 1 further comprising a pharmaceutically acceptable carrier.
5 . A composition comprising a conjugate represented by the following Formula (II):
wherein R′ is derived from a first compound comprising at least one reactive amide group, R″ is derived from a second compound comprising at least one reactive aminooxy group, wherein the second compound is selected from the group consisting of a polymer, a polysaccharide, a saccharide, a nucleic acid and a small molecule, and X is H, C n H (n+2) .
6 . The composition of claim 5 further comprising at least one additional N-oxime bond so as to form a crosslinked composition.
7 . The composition of claim 5 wherein the first compound is selected from the group consisting of a polymer, a protein, a peptide, a polysaccharide, a saccharide, a nucleic acid and a small molecule.
8 . The composition of claim 5 further comprising a pharmaceutically acceptable carrier.Join the waitlist — get patent alerts
Track US2015118178A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.